Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-79,982
Closed -$3.41M 73
2015
Q4
$3.41M Sell
79,982
-2,420
-3% -$111K 2.76% 14
2015
Q3
$3.91M Sell
82,402
-2,270
-3% -$116K 3.24% 9
2015
Q2
$4.19M Sell
84,672
-1,578
-2% -$80K 3.01% 13
2015
Q1
$4.26M Buy
86,250
+52,265
+154% +$2.5M 2.94% 15
2014
Q4
$1.55M Buy
+33,985
New +$1.65M 1.04% 33

Other funds holding SNY

Lipe & Dalton's SNY Position: Q1 2016 in Review

Lipe & Dalton sold out of Sanofi (SNY) in Q1 2016, closing a stake of 79,982 shares — an estimated $3.41M sold.

Lipe & Dalton first reported a position in SNY in Q4 2014 and held it in 5 quarters. The position peaked at $4.26M in Q1 2015. 449 funds tracked by Wall St. Rank hold SNY as of Q1 2016.

  • Lipe & Dalton reported no remaining Sanofi position as of Q1 2016 after selling out during the quarter.
  • Lipe & Dalton sold 79,982 Sanofi shares in Q1 2016, an estimated $3.41M.
  • Lipe & Dalton first reported a position in Sanofi in Q4 2014 and held it in 5 quarters.
  • Lipe & Dalton's Sanofi position peaked at $4.26M in Q1 2015.
  • 449 funds tracked by Wall St. Rank held Sanofi as of Q1 2016.

Based on Lipe & Dalton's 13F filing for Q1 2016, filed 12 May 2016.